Allergan and Asterand sign exclusive license agreement for preclinical compounds for eye diseases Sep. 15, 2008 No Comments
FDA grants fast track designation to Neurotech's NT-501 for retinitis pigmentosa and dry AMD Sep. 5, 2008 No Comments
Asterand enters license agreement with Allergan for prostaglandin receptor agonists Aug. 29, 2008 No Comments
Regeneron and Bayer HealthCare announce results from a phase II study of VEGF Trap-Eye Aug. 20, 2008 No Comments
RSS